Watch for Zelnorm to Return for Irritable Bowel Syndrome

October 2019

Zelnorm (tegaserod) may show up on home med lists...now that it's back on the market for women with irritable bowel syndrome.

It was taken off the market in 2007...due to reports of heart attack, stroke, and other cardiovascular (CV) problems.

Since then, it's been available on a case-by-case basis from various manufacturers.

Practical advice for a better career, with unlimited access to CE

Hospital Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Controlled Substances Help Protect Your Workplace Against Drug Diversion
Insulin Be Prepared if Your Pharmacy Stocks the New Insulin Premix, Myxredlin
Practice Use Strategies to Promote Teamwork in Your Pharmacy
Fungal Infections Follow Contact Precautions for Patients With Candida auris
Pain Management Look for Buprenorphine Dose Changes for Some Surgery Patients
Antibiotics Expect the New Pneumonia Antibiotic, Xenleta, to Be Saved for Rare Occasions
Influenza Get Ready to Dispense 2019-2020 Influenza Vaccines
Contraceptives Slynd, a New Oral Contraceptive, May Pop Up on Home Med Lists
IBS Watch for Zelnorm to Return for Irritable Bowel Syndrome
E-Cigarettes Don't Be Surprised to See Inpatients With Lung Injury From E-Cigs